Silva OHC, Opalin GL, Silva JA, Castillo BG, Tenorio MR, Martínez SRT

Language: Spanish
References: 12
Page: 252-256
PDF size: 148.02 Kb.

ABSTRACT

The main target for this study was to compare trans anesthetic and postoperatory effects of the ropivacain 0.75% intratecal only one dose in relation to the bupivacaine 0.5% on operated patients of lower extremities orthopedic surgery. Material and Methods: With a previous authorization of the Hospital Ethic Committee, 128 patient of different adults ages.ASAI-IV, were studied and divided randomized into two groups: Group I ropivacaine0.75%(3ml) and Group II bupivacaine0.5%(3ml) subjected to regional intratecal anesthesia. It was compared the quality of the sensitive block and the motor block as we as the time of recovery of the motor block .We also calculated the value of the residual analgesic in each group of patients. Anstatistic analysis of the variable was made taking asa base: average and Standard desviation to compare the analysis a "T" test Student (p𗿉0.05) was realized. Results: It was calculated the value of the sensitive block reporting in Group I 10.46±1.46 metameras and in Group II 13.51±2.65 metameras with one p‹0.0001. The motor block reported a quicker recovery in Group I with 229.29±21.94 minutes in relation to 266.09±21.42 minutes of Group II with p‹0.0001. Postoperatory analgesic of Group I was 9.48±1.82 hours and of 5.65±1.05 hours in the Group II (p‹ 0.0001). Conclusions: In our study ropivacaine 0.75% showed more effectiveness as local anesthetic intra the calcompared to bupivacaína al 0.5% as it showed a more lasting residual analgesic as well as motor block recovery an a less time and without big hemodynamic effects.

REFERENCES

1. Akerman B. Local anesthetic efficacy of LEA13- an experimental xylidide agent.Anesthesiology 1986;65:A217.

2. FederselH.Anefficientsynthesisofanew,chiral2’6‘-pipecoloxylidide local -anaesthetic agent.ActaChemicaScand1987;B41:757-761.

3. Akerman B. Primary evaluation of the local anaesthet properties of the amino amide agent ropivacaína (LEA103).ActaAnesthesiol Scand1988;32:571-578.

4. MatherLE,EdwardsSR.Chiralityinanaesthesia-ropivacaine,ketamina and thiopentone. Curr opinionAnaesth 1998;4:383-390.

5. ReynoldsF.Ropivacaine.Anaesthesia1991,46:339-340.

6. McClureJH.Ropivacaína.BrJAnaesth1996;76:300-307.

7. Gautier Ph, Kock M, Van steenberge A.Acomparision between intrathecal bupivacaíne and intrathecal ropivacaína for knee arthroscopyAnesthesiology 1999;91:5.

8. vanKleftJW,VeeringB.Spinalanesthesiawithropivacaína:adoubleblind study on the efficacy and safety of o.5% and 0.75% solutions in patients undergoing minor lower limb surgery. Anesth Analg 1994;78:1125-1130.

9. Rosenberg PH,Kytta J,Alila A. Absorption of bupivacaine, etodidocaina, Lignocaine and ropivacaine into N-heptane, rat sciatic nerve and human estradural and subcutaneous fat. Br J Anaesth 1986; 58:310-4.

10. Kock M, Gautier Ph. Intrathecal ropivacaína and clonidina for ambulatory knee artroscopyAnesthesiology 2001;94:574-578.

11. VeeringBT, Burmagl, van kleefJW, et al:SpinalAnaesthesia with glucose-free bupivacaine-effect of age on neurl blockade and pharmacokinetics.AnesthAnalg1987;66:965-70.

12. Koining H, KrennCG, GlaserCet al:Thedose-response of caudal ropivacaine in children.Anesthesiology 1999;90:1339-1344.